- Home
- JOB vs QTTB Comparison
JOB vs QTTB Comparison
Compare JOB & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- QTTB
- Stock Information
- Founded
- JOB 1893
- QTTB 2015
- Country
- JOB United States
- QTTB United States
- Employees
- JOB N/A
- QTTB N/A
- Industry
- JOB Diversified Commercial Services
- QTTB Biotechnology: Pharmaceutical Preparations
- Sector
- JOB Consumer Discretionary
- QTTB Health Care
- Exchange
- JOB Nasdaq
- QTTB Nasdaq
- Market Cap
- JOB 23.0M
- QTTB 23.3M
- IPO Year
- JOB N/A
- QTTB N/A
- Fundamental
- Price
- JOB $0.21
- QTTB $2.99
- Analyst Decision
- JOB
- QTTB Hold
- Analyst Count
- JOB 0
- QTTB 7
- Target Price
- JOB N/A
- QTTB $12.17
- AVG Volume (30 Days)
- JOB 315.0K
- QTTB 290.2K
- Earning Date
- JOB 08-13-2025
- QTTB 11-06-2025
- Dividend Yield
- JOB N/A
- QTTB N/A
- EPS Growth
- JOB N/A
- QTTB N/A
- EPS
- JOB N/A
- QTTB N/A
- Revenue
- JOB $108,752,000.00
- QTTB N/A
- Revenue This Year
- JOB $43.94
- QTTB N/A
- Revenue Next Year
- JOB N/A
- QTTB N/A
- P/E Ratio
- JOB N/A
- QTTB N/A
- Revenue Growth
- JOB N/A
- QTTB N/A
- 52 Week Low
- JOB $0.17
- QTTB $1.35
- 52 Week High
- JOB $0.51
- QTTB $53.17
- Technical
- Relative Strength Index (RSI)
- JOB N/A
- QTTB 84.33
- Support Level
- JOB N/A
- QTTB $1.79
- Resistance Level
- JOB N/A
- QTTB $2.11
- Average True Range (ATR)
- JOB 0.00
- QTTB 0.15
- MACD
- JOB 0.00
- QTTB 0.09
- Stochastic Oscillator
- JOB 0.00
- QTTB 94.81
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About QTTB Q32 Bio Inc. Common Stock
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.